Table 1 Physiochemical characterization of the formulations
From: Imaging asparaginyl endopeptidase (AEP) in the live brain as a biomarker for Alzheimer’s disease
Formulation | Particle size (nm) | PDI | Zeta potential(mV) |
|---|---|---|---|
AuNPs | 28.96 ± 0.22 | 0.180 ± 0.002 | − 32.63 ± 1.397 |
AuNPs-AK | 54.55 ± 1.14 | 0.224 ± 0.01 | − 22.6 ± 0.31 |
AuNPs-CABT | 44.37 ± 1.75 | 0.246 ± 0.003 | − 12.63 ± 0.75 |